|
|||||
|
|
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes |
|
| Authors: | Signe Schmidt MD Christian S. Frandsen MD Thomas F. Dejgaard MD Dorte Vistisen MSc Thórhallur Halldórsson MSc Sjudur F. Olsen MSc Jens-Erik B. Jensen MD Sten Madsbad MD Henrik U. Andersen MD Kirsten Nørgaard MD |
| Affiliation: | 1. Clinical Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark;2. Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark Department of Obstetrics and Gynecology, Rigshospitalet, Glostrup, Denmark;3. Clinical Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark Department of Public Health, University of Copenhagen, Copenhagen, Denmark;4. Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, Reykjavik, Iceland;5. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark;6. Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark;7. Clinical Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark |
| Abstract: | |
| Keywords: | body composition food frequency insulin pump therapy liraglutide type 1 diabetes weight loss |